RecruitingNot ApplicableNCT07768423

The Impact of Omega-3 Fatty Acid Supplementation on the Composition of Erythrocyte Membranes in Athletes

Effects of Omega-3 Fatty Acid Supplementation on Omega-3 Index, Cognitive Function, Hormonal Profile, Speed, and Endurance in Competitive Athletes Aged 16-35 Years: A Randomized Placebo-Controlled Trial


Sponsor

The Jerzy Kukuczka Academy of Physical Education in Katowice

Enrollment

200 participants

Start Date

Jan 7, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to evaluate the effects of omega-3 fatty acid supplementation on the Omega-3 Index, erythrocyte membrane composition, cognitive function, hormonal profile, speed, endurance performance, and hematological parameters in competitive athletes aged 16-35 years.


Eligibility

Min Age: 16 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying EPA + DHA supplements and Placebo for people with cognitive function, physical performance, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 16 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTEPA + DHA supplements

Participants will randomly assigned to the supplemented group. The supplement will be administered in a dose of 4 capsules twice a day for 4 weeks. Daily dose will contain 3500mg EPA + DHA

DIETARY_SUPPLEMENTPlacebo

Participants will randomly assigned to the Placebo group. The placebo will be administered in a dose of 4 capsules twice a day for 4 weeks. Daily dose will contain 3500mg MCT.


Locations(1)

Jerzy Kukuczka Academy of Physical Education in Katowice

Katowice, Mikolowska 72a, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07768423


Related Trials